These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 22024507

  • 1. Evolution and involution of atherosclerosis and its relationship with vascular reactivity in hypercholesterolemic rabbits.
    Ozaki MR, de Almeida EA.
    Exp Toxicol Pathol; 2013 Mar; 65(3):297-304. PubMed ID: 22024507
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ, Aregawi D, Agloria M, Khalil Q, Winiarska M, Munjal J, Gogineni S, Wang P.
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the antiatherosclerotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterolemic rabbits.
    Takayama M, Matsubara M, Arakawa E, Takada C, Ina Y, Hasegawa K, Yao K.
    Vascul Pharmacol; 2007 Apr; 46(4):302-8. PubMed ID: 17197250
    [Abstract] [Full Text] [Related]

  • 5. Rosuvastatin prevents myocardial necrosis in an experimental model of acute myocardial infarction.
    Dourado PM, Tsutsui JM, Landim MB, Casella Filho A, Galvao TF, Aiello VD, Mathias W, da Luz PL, Chagas AC.
    Braz J Med Biol Res; 2011 May; 44(5):469-76. PubMed ID: 21445530
    [Abstract] [Full Text] [Related]

  • 6. Cardiac hypertrophy during hypercholesterolemia and its amelioration with rosuvastatin and amlodipine.
    Kang BY, Wang W, Palade P, Sharma SG, Mehta JL.
    J Cardiovasc Pharmacol; 2009 Oct; 54(4):327-34. PubMed ID: 19687748
    [Abstract] [Full Text] [Related]

  • 7. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels.
    Wang Z, Zou J, Cao K, Hsieh TC, Huang Y, Wu JM.
    Int J Mol Med; 2005 Oct; 16(4):533-40. PubMed ID: 16142383
    [Abstract] [Full Text] [Related]

  • 8. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [Abstract] [Full Text] [Related]

  • 9. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function.
    Pirro M, Schillaci G, Romagno PF, Mannarino MR, Bagaglia F, Razzi R, Pasqualini L, Vaudo G, Mannarino E.
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):14-21. PubMed ID: 19158317
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
    Kosoglou T, Statkevich P, Yang B, Suresh R, Zhu Y, Boutros T, Maxwell SE, Tiessen R, Cutler DL.
    Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
    [Abstract] [Full Text] [Related]

  • 11. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 12. Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia.
    Pirro M, Schillaci G, Mannarino MR, Savarese G, Vaudo G, Siepi D, Paltriccia R, Mannarino E.
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):436-41. PubMed ID: 17134956
    [Abstract] [Full Text] [Related]

  • 13. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
    Guo H, Shi Y, Liu L, Sun A, Xu F, Chi J.
    Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
    [Abstract] [Full Text] [Related]

  • 14. [Role of rosuvastatin in current lipid-lowering therapy].
    Abel T, Fehér J.
    Orv Hetil; 2010 Aug 29; 151(35):1424-8. PubMed ID: 20719717
    [Abstract] [Full Text] [Related]

  • 15. Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin.
    Tomizawa A, Hattori Y, Suzuki K, Okayasu T, Kase H, Satoh H, Kasai K.
    Int J Cardiol; 2010 Sep 24; 144(1):108-9. PubMed ID: 19174316
    [No Abstract] [Full Text] [Related]

  • 16. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial.
    Underhill HR, Yuan C, Zhao XQ, Kraiss LW, Parker DL, Saam T, Chu B, Takaya N, Liu F, Polissar NL, Neradilek B, Raichlen JS, Cain VA, Waterton JC, Hamar W, Hatsukami TS.
    Am Heart J; 2008 Mar 24; 155(3):584.e1-8. PubMed ID: 18294500
    [Abstract] [Full Text] [Related]

  • 17. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov 24; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).
    Bays HE, Davidson MH, Massaad R, Flaim D, Lowe RS, Tershakovec AM, Jones-Burton C.
    Am J Cardiol; 2011 Aug 15; 108(4):523-30. PubMed ID: 21596364
    [Abstract] [Full Text] [Related]

  • 19. Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction.
    Deguchi I, Horiuchi Y, Hayashi T, Sehara Y, Kato Y, Ohe Y, Fukuoka T, Maruyama H, Sano H, Nagamine Y, Tanahashi N.
    J Stroke Cerebrovasc Dis; 2014 Sep 15; 23(8):2007-2011. PubMed ID: 25066602
    [Abstract] [Full Text] [Related]

  • 20. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).
    Ballantyne CM, Pitt B, Loscalzo J, Cain VA, Raichlen JS.
    Am J Cardiol; 2013 Feb 15; 111(4):506-9. PubMed ID: 23237107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.